Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonism.

Cutler, N R

Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonism. [electronic resource] - Clinical pharmacokinetics Mar 1992 - 223-30 p. digital

Publication Type: Journal Article

0312-5963

10.2165/00003088-199222030-00004 doi


Administration, Oral
Aged
Antiparkinson Agents--adverse effects
Delayed-Action Preparations
Dopamine Agents--adverse effects
Dose-Response Relationship, Drug
Female
Humans
Lactose--adverse effects
Male
Methylcellulose--adverse effects
Middle Aged
Oxazines
Parkinson Disease--blood
Tablets